CATALYST DOSSIER · UPDATED 2026-11-12
$HSCT
tech · convergence -23 · conviction AVOID
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $HSCT?
Quantitative
Convergence score : -23 (4 signals firing YoY)
Catalysts
Multi-spoke convergence : 4 convergent signals fired: auto_macro_adp_payrolls, auto_macro_banrep_colombia, auto_macro_bls_employment, auto_macro_durable_goods
Risks
Position-sizing discipline : Conviction AVOID (-23 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Multiple compression : If breadth deteriorates, tech-wide multiples re-rate lower regardless of pick-specific thesis
Sympathy basket (cerebro)
NVDA via semis r=+0.96 sympathetic (score 15)
CBRS via semis r=+0.96 sympathetic (score 5)
LUNR via industrials r=+0.83 sympathetic (score 26)
IBP via industrials r=+0.83 sympathetic (score 17)
MGTX via biotech r=+0.78 sympathetic (score 25)
TSHA via biotech r=+0.78 sympathetic (score 23)
Signals Firing
auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-29 sec_top_gappers +0.0% +0.0% — 2026-10-29 sec_top_moat_emerging +0.0% +0.0% — 2026-10-27 sec_top_gappers +0.0% +0.0% — 2026-10-27 sec_top_moat_emerging +0.0% +0.0% — 2026-10-26 sec_top_gappers +0.0% +0.0% — 2026-10-26 sec_top_moat_emerging +0.0% +0.0% —
Lifetime: 0/6 wins · hit-rate 0.0% on +2% intraday
Sympathy Basket NVDA via semis · score 15 CBRS via semis · score 5 LUNR via industrials · score 26 IBP via industrials · score 17 MGTX via biotech · score 25 TSHA via biotech · score 23
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.